PEPG PepGen Inc.

NASDAQ
$2.99

PepGen Inc. (PEPG) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +42.4% since its last earnings release on August 6, 2026.

PepGen Beat Consensus Estimates
Thursday, August 6, 2026 · 7:32 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.27)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.74

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About PepGen Inc.

PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen Inc. is based in BOSTON.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow